1. Article | 2020.10.14

   Covid-19: A vaccine candidate using a lentiviral vector

   This vaccine candidate for the SARS-CoV-2 virus, designed for nasal administration, demonstrated intense protection and extremely high production of antibodies and cytotoxic cell responses in preclinical trials.

2. News | 2020.04.15

   COVID-19 - The Bioinformatics and Biostatistics Hub on the front line

   Like many other research teams at the Institut Pasteur, the Bioinformatics and Biostatistics Hub is engaged in fighting against the COVID-19 pandemic by participating in the curation of GISAID data (Global Initiative on Sharing All Influenza Data). The Hub is the service division of the Computational Biology Department, and is composed of 50 experts in biostatistics and bioinformatics.At the end...

3. Page avancée | 2020.06.17

   All SARS-CoV-2 / COVID-19 from the Institut Pasteur

   All SARS-CoV-2 / COVID-19 from the Institut Pasteur

4. Vidéo | 2020.02.20

   COVID-19 : What we have learnt as of 20 February 2020

   COVID-19 : What we have learnt as of 20 February 2020

5. Article | 2020.06.22

   Fiche maladie redirect en Sars-CoV-2 / Covid-19

   Fiche maladie redirect en Sars-CoV-2 / Covid-19

6. Article | 2020.07.07

   COVID-19 - The Bioinformatics and Biostatistics Hub on the front line

   COVID-19 - The Bioinformatics and Biostatistics Hub on the front line

7. News | 2023.02.20

   Two effective new antiviral drugs for SARS-CoV-2

   Scientists at the Institut Pasteur have successfully synthesized two novel molecules that are active against several variants of the virus responsible for COVID-19. The discovery could inspire new families of antiviral drugs against future emerging viral diseases.

8. Événement | 2021.10.07

   COVID-19, cancers, antibiotic resistance: meet the researchers at the Institut Pasteur

   On the occasion of the 15th edition of the Pasteurdon, join the Institut Pasteur, on Thursday, October 7, in partnership with Figaro Partner, for an online program on the major current public health issues: COVID-19, cancers, antibiotic resistance. See you on October 7 on the Pasteurdon website.

9. News | 2021.10.18

   "COVID-19, cancers and antibiotic resistance: meeting the researchers of the Institut Pasteur": programme available for replay

   For the opening of the Pasteurdon 2021, scientists from the Institut Pasteur took part in a digital programme looking at some of the major current issues in medical research, "COVID-19, cancers and antibiotic resistance: meeting Institut Pasteur researchers", in partnership with Figaro Partner. Watch online (in French).

10. News | 2021.10.18

    The replay of the conference "COVID-19, Advances and Remaining Challenges" is available

    For three days, worldwide specialists shared their views about the pandemic during a congress hosted by the Institut Pasteur. Their contributions are to be found online.

Pages